CD81 promotes proliferation and predicts survival in lung squamous cell carcinoma

Ryu Kanzaki; Steven Reid; Paulina Bolivar; Sara Larsson; Yasushi Shintani; Kristian Pietras

doi:10.1002/ctm2.70672

Clinical and Translational Medicine ›› 2026, Vol. 16 ›› Issue (4) :e70672 DOI: 10.1002/ctm2.70672

LETTER TO THE JOURNAL

CD81 promotes proliferation and predicts survival in lung squamous cell carcinoma

Author information +

History +

PDF (5254KB)

Keywords

CD81 / lung squamous cell carcinoma

Cite this article

Download citation ▾

Ryu Kanzaki, Steven Reid, Paulina Bolivar, Sara Larsson, Yasushi Shintani, Kristian Pietras. CD81 promotes proliferation and predicts survival in lung squamous cell carcinoma. Clinical and Translational Medicine, 2026, 16 (4) : e70672 DOI:10.1002/ctm2.70672

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Vences-Catalan F, Duault C, Kuo CC, Rajapaksa R, Levy R, Levy S. CD81 as a tumor target. Biochem Soc Trans. 2017; 45(2): 531-535.

[2]	Ye X, Deng J, Dong C, Pan X, Lu Y. Characterization and verification of CD81 as a potential target in lung squamous cell carcinoma. Biochem Biophys Res Commun. 2024; 692:149344.

[3]	Kanzaki R, Reid S, Bolivar P, et al. FHL2 expression by cancer-associated fibroblasts promotes metastasis and angiogenesis in lung adenocarcinoma. Int J Cancer. 2024; 156(2): 431-446.

[4]	Cheng Y, Wen G, Sun Y, et al. Osteopontin promotes colorectal cancer cell invasion and the stem cell-like properties through the PI3K‒AKT‒GSK/3β-β/catenin pathway. Med Sci Monit. 2019; 25: 3014-3025.

[5]	Qian S, Wang F, Liao W, Liu J. The role of HMGA2 in activating the IGFBP2 expression to promote angiogenesis and LUAD metastasis via the PI3K/AKT/VEGFA signaling pathway. Neoplasma. 2024; 71(1): 22-36.

[6]	Ramos EK, Tsai CF, Jia Y, et al. Machine learning-assisted elucidation of CD81‒CD44 interactions in promoting cancer stemness and extracellular vesicle integrity. eLife. 2022; 11:e82669.

[7]	Suwatthanarak T, Usuba K, Kuroha K, Tanaka M, Okochi M. Screening of EWI-2-derived peptides for targeting tetraspanin CD81 and their effect on cancer cell migration. Biomolecules. 2023; 13(3): 510.

[8]	Abu-Saleh N, Kuo CC, Jiang W, Levy R, Levy S. The molecular mechanism of CD81 antibody inhibition of metastasis. Proc Natl Acad Sci U S A. 2023; 120(26):e2305042120.

RIGHTS & PERMISSIONS

2026 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.